Psilocybin Polymorph A for Anxiety, Headache, and Eating Disorders

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for improved compositions and methods for treating anxiety disorders, headache disorders, and eating disorders, as existing treatments are inadequate.

Innovation Solution

Administering a therapeutically effective amount of psilocybin or its active metabolite to subjects suffering from these disorders, often in a highly pure crystalline form of Polymorph A, along with psychological support sessions before and after administration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If existing treatments are used for anxiety disorders, headache disorders, and eating disorders, then current standard therapies are applied, but treatment adequacy is insufficient

Engineering Contradiction:
Improvetreatment adequacyVSAvoidtreatment effectiveness across multiple disorder types
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent applies psilocybin as a universal treatment agent for multiple distinct psychiatric and neurological disorders including anxiety disorders, headache disorders, and eating disorders. The compound demonstrates multi-functionality by effectively treating diverse conditions through a single therapeutic intervention, resolving the contradiction between treatment adequacy and adaptability across disorder types

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Manufacturing precision

If psilocybin is administered in highly pure crystalline form of Polymorph A, then manufacturing precision and purity are improved, but device complexity and formulation requirements increase

Engineering Contradiction:
Improvecrystalline purityVSAvoidformulation complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent specifies precise crystalline parameters for Polymorph A including defined X-ray diffraction patterns, melting points, and solubility characteristics. By controlling these physical-chemical parameters during manufacturing, high purity is achieved while the standardized specification framework actually simplifies formulation development and quality control processes

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS12447164B2Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
Publication Date: 2025.10.21 COMPASS PATHFINDER LTD
  • US12447164B2 patent drawing
  • US12447164B2 patent drawing
  • US12447164B2 patent drawing

AI summary

The disclosure provides methods for treating a subject in need thereof comprising administering to the subject a therapeutically-effective dose of psilocybin. The methods described herein may be used to treat a variety of diseases, disorders, and conditions. For example, the methods may be used to treat anxiety disorders, eating disorders, and headache disorders.